Pulmonary Hypertension (PH) is a complex and often misunderstood condition. Despite advancements in diagnostic tools and therapeutic options, it remains a significant cause of morbidity and mortality. This article aims to provide a comprehensive guide to help healthcare professionals better understand and manage PH.
PH is defined as a mean pulmonary arterial pressure ≥25 mmHg at rest, confirmed by right heart catheterization. It is classified into five groups based on etiology, clinical presentation, hemodynamic characteristics, and treatment strategy. This classification aids in the understanding of disease pathophysiology and guides therapeutic decision-making.
The pathophysiology of PH is multifactorial and involves vasoconstriction, vascular remodeling, and thrombosis in situ. The imbalance between vasoconstrictive and vasodilative substances, along with endothelial dysfunction, leads to increased pulmonary vascular resistance, resulting in right heart failure.
Diagnosis of PH is challenging due to the nonspecific nature of symptoms. A high index of suspicion is required for early detection. An echocardiogram is the initial screening tool, followed by right heart catheterization to confirm the diagnosis. Additional investigations like pulmonary function tests, CT scan, and V/Q scan may be needed based on the suspected etiology.
Management of PH is complex and requires a multidisciplinary approach. It includes general measures, targeted drug therapy, and surgical interventions. Early diagnosis and treatment can significantly improve the prognosis. Patient education and regular follow-up are vital elements of management.
PH is a challenging condition that requires a thorough understanding of its fundamentals for effective management. As healthcare professionals, it is our responsibility to stay abreast with the latest advancements in the field to provide optimal care to our patients. A comprehensive understanding of PH will undoubtedly contribute to better patient outcomes.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation